Model Number FR8A-RCV-A0, FR8A-SPR-B0 |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problem
Myocardial Infarction (1969)
|
Event Date 03/16/2023 |
Event Type
Injury
|
Manufacturer Narrative
|
The other adverse events issues questionnaire was reviewed for potential causes of the reported issue.Based on this review, the incident taking place before the implant of the device, using the waa during the incident, implanting the device at an off-label location, and implanting the stimulator too close to the targeted nerve have been ruled out as potential causes.Additionally, the doctor obtained cardiac clearance before the procedure.The stimulator is used to treat pain.The cause of the cardiac arrest is unknown.Therefore, conclusion has been selected as no problem/fault found, as there is no evidence at this time that the device may have caused or contributed to the event.Rates reviewed at the most recent complaint trending meeting do not indicate a significant increase in other adverse events issues.Other adverse events issues rates remain acceptably low; thus, capa is not required. other adverse events issue rates will continue to be tracked and trended.
|
|
Event Description
|
The patient reported cardiac arrest the day following the implant procedure.They were taken to the hospital and were in the icu as of (b)(6) 2023.The patient was not using the device when the cardiac arrest occurred and it is unknown if the device will be explanted.
|
|
Event Description
|
The patient reported a heart attack the day following the implant procedure.They were taken to the hospital and were in the icu.The patient was not using the device when the heart attack occurred.The patient spent approximately 6 weeks in the hospital and rehab.The patient began using their transmitter assembly on (b)(6) 2023.
|
|
Manufacturer Narrative
|
The other adverse events issues questionnaire was reviewed for potential causes of the reported issue.Based on this review, the incident taking place before the implant of the device, using the waa during the incident, implanting the device at an off-label location, and implanting the stimulator too close to the targeted nerve have been ruled out as potential causes.Additionally, the doctor obtained cardiac clearance before the procedure.The stimulator is used to treat pain.The cause of the heart attack is unknown.The investigation findings do not lead to a clear conclusion about the cause of the reported issue.Therefore, conclusion has been selected as unable to determine root cause.Rates reviewed at the most recent complaint trending meeting do not indicate a significant increase in other adverse events issues.Other adverse events issues rates remain acceptably low; thus, capa is not required. other adverse events issue rates will continue to be tracked and trended.Updated per fda capa-2023-0013 correction 2.
|
|
Search Alerts/Recalls
|